U.S. House Committee on Energy and Commerce Advances Bipartisan… Read More
Analysis Finds Brand Name Drug Companies Declined to Even Attempt a Defense of… Read More
Makary Highlights and Adds to Momentum “Across the Political Spectrum” to… Read More
Report Underscores How Competition Lowers Prescription Drug Prices by… Read More
Patent Abuse Blocked Competition From More Affordable Alternatives For Periods… Read More
Highest Priced Brand Name Treatments Showcase Big Pharma’s Rising Launch… Read More
Gilead and Eli Lilly Latest Brand Name Drug Companies to Hike Prices… Read More
Amgen and Pfizer Bring in Billions of Revenue in Q2 Following Continued Price… Read More
Joint DOJ-FTC Listening Session Focuses on Solutions to Foster Greater… Read More
The Wall Street Journal Finds Pharma-Backed Provision Likely to Enable Big… Read More
AbbVie and Bristol Myers Squibb Report Better-Than-Expected Earnings in the… Read More
Pair of Big Pharma Giants Beat Expectations After Hiking Prices on Nearly 50… Read More